Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

INTRODUCTION: Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Nordström, Tobias, Jäderling, Fredrik, Carlsson, Stefan, Aly, Markus, Grönberg, Henrik, Eklund, Martin
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Urology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6576112/
https://ncbi.nlm.nih.gov/pubmed/31201191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-027816
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares